封面
市場調查報告書
商品編碼
1738323

癌症診斷人工智慧市場—全球產業規模、佔有率、趨勢、機會和預測(按技術、癌症類型、最終用戶、地區和競爭細分,2020-2030 年)

Artificial Intelligence In Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Cancer Type, By End-User, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年,全球癌症診斷人工智慧市場規模達1.2847億美元,預計將大幅成長,到2030年將達到2.0862億美元,預測期內複合年成長率為8.54%。人工智慧正在改變癌症診斷方式,透過分析影像掃描和基因組圖譜等複雜醫學資料,能夠更快、更準確地檢測出惡性腫瘤。隨著全球癌症發生率的上升,對能夠改善臨床療效的早期檢測工具的需求也不斷成長。人工智慧診斷平台可以識別傳統方法無法識別的資料中的細微模式,提高診斷準確性,同時減少診斷時間和人為錯誤。這對於乳癌、肺癌和大腸癌等高負擔癌症尤其重要。技術進步、癌症盛行率的上升以及對精準醫療的大力推動是推動市場擴張的關鍵因素。此外,DELFI的肝癌人工智慧血液檢測等成功應用凸顯了人工智慧在改善早期診斷和長期存活率方面的潛力。

市場概覽
預測期 2026-2030
2024年市場規模 1.2847億美元
2030年市場規模 2.084億美元
2025-2030 年複合年成長率 8.54%
成長最快的領域 醫院
最大的市場 北美洲

關鍵市場促進因素

癌症發生率上升和早期檢測需求推動全球癌症診斷人工智慧市場的發展

主要市場挑戰

數據品質和數量對市場擴張構成重大障礙

主要市場趨勢

技術進步

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:全球癌症診斷人工智慧市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按技術(軟體解決方案、硬體、服務)
    • 依癌症類型(乳癌、肺癌、攝護腺癌、大腸癌、腦瘤、其他)
    • 按最終使用者(醫院、外科中心和醫療機構等)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美癌症診斷人工智慧市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲癌症診斷人工智慧市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章:亞太地區癌症診斷人工智慧市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲癌症診斷人工智慧市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東和非洲癌症診斷人工智慧市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 促進要素
  • 挑戰

第 12 章:市場趨勢與發展

第 13 章:全球癌症診斷人工智慧市場:SWOT 分析

第 14 章:競爭格局

  • Medial EarlySign
  • Cancer Center.ai
  • Microsoft Corporation
  • Flatiron Health
  • Path AI
  • Therapixel
  • Tempus Labs, Inc.
  • Paige AI, Inc.
  • Kheiron Medical Technologies Limited
  • SkinVision

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16238

The Global Artificial Intelligence in Cancer Diagnostics Market was valued at USD 128.47 million in 2024 and is projected to grow significantly, reaching USD 208.62 million by 2030 with a CAGR of 8.54% during the forecast period. AI is transforming cancer diagnostics by enabling faster, more accurate detection of malignancies through the analysis of complex medical data such as imaging scans and genomic profiles. As cancer incidence rises globally, the demand for early detection tools that enhance clinical outcomes is accelerating. AI-powered diagnostic platforms can identify subtle patterns in data that might elude traditional methods, improving accuracy while reducing diagnostic time and human error. This has proven particularly valuable for high-burden cancers like breast, lung, and colorectal cancer. Technological advancements, increasing cancer prevalence, and a strong push for precision medicine are key factors driving market expansion. Moreover, successful applications such as DELFI's AI blood test for liver cancer highlight the potential of AI to improve early-stage diagnosis and long-term survival.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 128.47 Million
Market Size 2030USD 208.40 Million
CAGR 2025-20308.54%
Fastest Growing SegmentHospital
Largest MarketNorth America

Key Market Drivers

Rising Cancer Incidence and Demand for Early Detection is Driving the Global Artificial Intelligence In Cancer Diagnostics Market

With cancer remaining a leading cause of death globally, early detection has become a top priority in healthcare systems. The growing incidence of cancer-attributed to aging populations, lifestyle factors, and environmental exposure-is driving demand for diagnostic tools that can catch tumors at their earliest and most treatable stages. AI is emerging as a game-changing technology in this regard. By analyzing extensive patient data, including radiologic and pathologic images, AI systems help clinicians identify malignancies faster and more accurately. For example, the American Cancer Society estimates over 2 million new cancer cases in the U.S. alone for 2024, underscoring the urgency for efficient diagnostic solutions. AI's ability to support rapid analysis and generate diagnostic insights across multiple cancer types enhances its value proposition, especially as healthcare providers seek scalable tools to meet increasing patient volumes and complexity in diagnostics.

Key Market Challenges

Data Quality and Quantity Poses a Significant Obstacle To Market Expansion

AI models require large, high-quality datasets to perform accurately and generalize effectively across populations. However, in cancer diagnostics, data availability and standardization remain significant hurdles. Variations in imaging protocols, inconsistent data labeling, and fragmented electronic health records can affect model training and limit diagnostic precision. Additionally, privacy concerns and regulatory barriers often restrict data sharing between institutions, limiting access to comprehensive datasets. These challenges slow the development of robust AI solutions and delay their clinical validation and deployment. Addressing this issue requires cross-institutional collaboration, anonymized data sharing frameworks, and rigorous data governance policies.

Key Market Trends

Technological Advancements

AI continues to advance rapidly, especially in areas such as machine learning, computer vision, and natural language processing. In cancer diagnostics, these technologies are enhancing image analysis, pathology workflows, and genomic profiling. AI algorithms now assist in detecting abnormalities in imaging scans with high precision, identifying early-stage tumors, and predicting treatment responses based on patient-specific genetic information. For instance, AI tools can detect textural or morphological changes in tissues that indicate early malignancies, which may not be visible to the human eye. Additionally, AI supports precision oncology by analyzing genomic mutations to match patients with targeted therapies. These technological innovations are improving diagnostic accuracy, reducing diagnostic delays, and enabling personalized treatment planning. As integration with clinical systems becomes more seamless, AI adoption in oncology diagnostics is expected to scale rapidly across healthcare institutions globally.

Key Market Players

  • Medial EarlySign
  • Cancer Center.ai
  • Microsoft Corporation
  • Flatiron Health
  • Path AI
  • Therapixel
  • Tempus Labs, Inc.
  • Paige AI, Inc.
  • Kheiron Medical Technologies Limited
  • SkinVision

Report Scope:

In this report, the Global Artificial Intelligence In Cancer Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Intelligence In Cancer Diagnostics Market, By Technology:

  • Software Solutions
  • Hardware
  • Services

Artificial Intelligence In Cancer Diagnostics Market, By Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

Artificial Intelligence In Cancer Diagnostics Market, By End User:

  • Hospital
  • Surgical Centres and Medical Institutes
  • Others

Artificial Intelligence In Cancer Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Intelligence In Cancer Diagnostics Market.

Available Customizations:

Global Artificial Intelligence In Cancer Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

4. Global Artificial Intelligence In Cancer Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Software Solutions, Hardware, Services)
    • 5.2.2. By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others)
    • 5.2.3. By End-User (Hospital, Surgical Centers and Medical Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Artificial Intelligence In Cancer Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Cancer Type
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Cancer Type
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Cancer Type
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Cancer Type
        • 6.3.3.2.3. By End-User

7. Europe Artificial Intelligence In Cancer Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Cancer Type
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Cancer Type
        • 7.3.1.2.3. By End-User
    • 7.3.2. United Kingdom Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Cancer Type
        • 7.3.2.2.3. By End-User
    • 7.3.3. Italy Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Cancer Type
        • 7.3.3.2.3. By End-User
    • 7.3.4. France Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Cancer Type
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Cancer Type
        • 7.3.5.2.3. By End-User

8. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Cancer Type
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Cancer Type
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Cancer Type
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Cancer Type
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Cancer Type
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Cancer Type
        • 8.3.5.2.3. By End-User

9. South America Artificial Intelligence In Cancer Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Cancer Type
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Cancer Type
        • 9.3.1.2.3. By End-User
    • 9.3.2. Argentina Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Cancer Type
        • 9.3.2.2.3. By End-User
    • 9.3.3. Colombia Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Cancer Type
        • 9.3.3.2.3. By End-User

10. Middle East and Africa Artificial Intelligence In Cancer Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Cancer Type
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Cancer Type
        • 10.3.1.2.3. By End-User
    • 10.3.2. Saudi Arabia Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Cancer Type
        • 10.3.2.2.3. By End-User
    • 10.3.3. UAE Artificial Intelligence In Cancer Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Cancer Type
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Driver
  • 11.2. Challenges

12. Market Trends & Developments

13. Global Artificial Intelligence In Cancer Diagnostics Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Medial EarlySign
    • 14.1.1. Business Overview
    • 14.1.2. Cancer Type Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. Cancer Center.ai
  • 14.3. Microsoft Corporation
  • 14.4. Flatiron Health
  • 14.5. Path AI
  • 14.6. Therapixel
  • 14.7. Tempus Labs, Inc.
  • 14.8. Paige AI, Inc.
  • 14.9. Kheiron Medical Technologies Limited
  • 14.10. SkinVision

15. Strategic Recommendations

16. About Us & Disclaimer